These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 34630107)

  • 41. Gut Microbiome and Alcohol-associated Liver Disease.
    Philips CA; Schnabl B; Bajaj JS
    J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Ranjbarian T; Schnabl B
    Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.
    Huang H; Lin Z; Zeng Y; Lin X; Zhang Y
    Exp Ther Med; 2019 Dec; 18(6):4733-4739. PubMed ID: 31777560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease.
    Scarlata GGM; Colaci C; Scarcella M; Dallio M; Federico A; Boccuto L; Abenavoli L
    Diseases; 2024 Mar; 12(4):. PubMed ID: 38667527
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Li H; Cheng S; Huo J; Dong K; Ding Y; Man C; Zhang Y; Jiang Y
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver.
    Gupta H; Suk KT; Kim DJ
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updated Insights into Probiotics and Hepatobiliary Diseases.
    Xu X; Zhang C; Tang G; Wang N; Feng Y
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut Microbiota and Hepatocellular Carcinoma.
    Tao X; Wang N; Qin W
    Gastrointest Tumors; 2015 May; 2(1):33-40. PubMed ID: 26673641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Microbiota and Alcoholic Liver Disease.
    Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
    Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcoholic liver disease: focus on prodromal gut health.
    Park B; Lee HR; Lee YJ
    J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.
    Liu SY; Tsai IT; Hsu YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbiome as a therapeutic target in alcohol-related liver disease.
    Sarin SK; Pande A; Schnabl B
    J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.